Cross-referencing clinical data
Source: NIH ODS + USPSTF 2018 + WHI calcium trial
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Calcium alpha-ketoisocaproate has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Alpha-ketoisocaproate is the keto acid of leucine, and branched-chain aminotransferase moves between the two in both directions. Supplying the keto acid with an amino group donor available regenerates leucine without adding nitrogen. The same is true in the other direction: leucine given in excess is deaminated to this keto acid.
Branched-chain aminotransferase is a pyridoxal-5-phosphate dependent enzyme, so the interconversion of this keto acid and leucine cannot run without adequate B6. This is a hard biochemical dependency, not a modest additive effect. It says nothing about whether extra B6 improves anything in someone already replete.
Pyridoxal-5-phosphate is the coenzyme form that transaminases actually use, so it enters the pathway without the conversion step that pyridoxine requires. The dependency is the same one described for B6 generally. Choosing between the two forms is a delivery question, and both feed the same reaction.
Onward oxidation of alpha-ketoisocaproate runs through the branched-chain alpha-keto acid dehydrogenase complex, whose first component needs thiamine pyrophosphate. Without thiamine, branched-chain keto acids accumulate rather than being oxidised. This is textbook, and it is why thiamine status matters wherever branched-chain load is raised.
The dihydrolipoyl dehydrogenase component of the branched-chain keto acid dehydrogenase complex carries FAD, which is built from riboflavin. The complex is a riboflavin-dependent machine in the same way pyruvate dehydrogenase is. The relationship is structural, so it holds regardless of dose.
The same dehydrogenase complex reduces NAD to NADH at its final step, so niacin-derived NAD is consumed by branched-chain keto acid oxidation. Cellular NAD supply is shared with many other pathways, which makes this less of a bottleneck than thiamine. It belongs in the mechanism map rather than in a dosing recommendation.
Further down the leucine catabolic route, 3-methylcrotonyl-CoA carboxylase is a biotin-dependent enzyme. Poor biotin status shows up as a specific pattern of leucine-pathway intermediates. That makes biotin a genuine part of the pathway rather than a general-purpose addition.
A minor cytosolic route converts alpha-ketoisocaproate to HMB via a dioxygenase, so the keto acid sits directly upstream of HMB. Only a small fraction of leucine flux takes that turn in humans. Taking both supplies the precursor and the product of the same short step.
Transamination of this keto acid back to leucine needs an amino group donor, supplied through the glutamate and glutamine pool. Where that pool is low, the keto acid is oxidised rather than converted. The pairing is about which direction the transaminase runs.
Valine, leucine and isoleucine share the same aminotransferase, the same dehydrogenase complex and the same LAT1 transporter at the cell membrane. Loading one branched-chain skeleton heavily shifts the handling of the other two. That competition is the reason branched-chain products are usually blended rather than given singly.
Whey is naturally high in leucine, so a whey dose already loads the same pathway this keto acid feeds. Stacking the two is additive rather than complementary. Where whey intake is already substantial, the marginal contribution of the keto acid is small.
The calcium in the salt competes with non-heme iron for uptake when the two arrive together. This has nothing to do with the keto acid and everything to do with the counter-ion. Separating the doses by a couple of hours resolves it.
Calcium taken in a single sizeable dose reduces zinc uptake in the same meal. Again, the interaction belongs to the salt rather than the active. It matters more for people relying on a marginal zinc intake.
A calcium salt of an organic acid contributes elemental calcium that most labels do not put on the front. Added to a dedicated calcium supplement, the day's total climbs without anyone intending it. Count both when tallying intake.
Calcium and magnesium share absorptive and renal handling, and a large calcium load shifts magnesium balance modestly. The effect is small at supplemental calcium doses of this size. Note it for people taking several calcium-salt products at once.
Nothing specific on file for Calcium alpha-ketoisocaproate. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.